HOME >> BIOLOGY >> NEWS
Genome of Clostridium botulinum reveals the background to world's deadliest toxin

The genome of the organism that produces the worlds most lethal toxin is revealed today. This toxin is the one real weapon in the genome of Clostridium botulinum and less than 2 kg the weight of two bags of sugar is enough to kill every person on the planet. Very small amounts of the same toxin are used in medical treatments, one of which is known as Botox.

The genome sequence shows that C. botulinum doesnt have subtle tools to evade our human defences or tricky methods of acquiring resistance to antibiotics. It lives either as a dormant spore or as a scavenger of decaying animal materials in the soil, and doesnt interact with human or other large animal hosts for prolonged periods of time.

Occasionally it gets into a living animal, via contaminated food or open wounds, leading to infant botulism or wound botulism, both of which are serious human infections. The host can be quickly overpowered and, in some cases, killed by the toxin, and C. botulinum has a new food source.

"Although in the same group as Clostridium difficile the Cdiff superbug C. botulinum has a genome that is remarkable because it is so stable," commented Dr Mohammed Sebaihia, lead author on the paper from the Wellcome Trust Sanger Institute. "Unlike Cdiff, in which more than 10 per cent of genes have been acquired from other bacteria, there is almost no footprint of these in C. botulinum."

There are several types of C. botulinum: although described as variants of a single species, they are really very different organisms linked simply because they have the deadly toxin. For each type, there is also a near-identical but harmless relative that lacks the toxin. C. sporogenes is the non-malignant, near twin of the organism sequenced.

Professor Mike Peck, from the Institute of Food Research, commented that "It is astonishing that 43 per cent of the predicted genes in the C. botulinum genome are absent from the other five sequenced clostridia, an
'"/>

Contact: Don Powell
press.officer@sanger.ac.uk
University of Nottingham
25-May-2007


Page: 1 2 3

Related biology news :

1. The Cancer Genome Atlas awards funds for technology development
2. DOE Joint Genome Institute secures long-term lease on production genomics facility
3. DOE JGI upgrades its Microbial Genome Analysis System
4. Genome Canada, Gnome Qubec and Universit de Montral launch P3G Consortium and CARTaGENE Project
5. Genome of yellow fever/dengue fever mosquito sequenced
6. Genome-wide search unearths surprising clues for diabetes and triglycerides
7. Latest advances in DNA sequencing highlighted at DOE Joint Genome Institute User Meeting
8. No pain, DOE Joint Genome Institute gains coveted ergonomics prize with Shake N Plate
9. DOE JGI releases enhanced Genome Data Management System IMG 2.1 marking 2-year anniversary
10. Genome sequencing reveals key to viable ethanol production
11. Genome scan for familial autism finds two new genetic links

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/12/2019)... ... April 11, 2019 , ... Neal O’Farrell is one of the first ... He is executive director of the consumer advocacy non-profit the Identity Theft Council as ... member of the Federal Communications Commission’s Cybersecurity Roundtable and is currently a fellow of ...
(Date:4/5/2019)... AUBURN, Mass. (PRWEB) , ... April 04, 2019 ... ... family is available with integrated linear encoders providing 0.05 microns and 0.005 microns ... prices. Many motor and drive variations are available, from fast DC-servo motors with ...
(Date:4/4/2019)... ... 03, 2019 , ... R3 Stem Cell is now offering ... of Excellence. R3 wants patients to feel secure when they make a significant ... Centers that use inferior regenerative biologics, protocols or amounts, R3 provides a safe ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... April 09, 2019 , ... ... the capacity of life sciences organizations to accelerate innovation and maximize productivity, announces ... in the past 12 months. , USDM’s Cloud Assurance is a ...
(Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
(Date:3/29/2019)... ... March 28, 2019 , ... ... testing milestones, CARB-X has proceeded with a second stage of funding for Specific’s ... million, which is on top of the $1.7 million already awarded by CARB-X. ...
(Date:3/23/2019)... (PRWEB) , ... March 22, 2019 , ... ... sample collection, and analysis to a team of researchers at Nnamdi Azikiwe University ... by Dr. Nneka R. Agbokoba, PhD, of the Department of Medical Laboratory Sciences ...
Breaking Biology Technology:
Cached News: